Alex R. Thurman serves as the Senior Vice President and Chief Financial Officer at GLAUKOS CORP, a leading ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. In his role, Thurman is responsible for overseeing the company's financial operations, including financial planning and analysis, accounting, tax, treasury, and investor relations. His strategic leadership has been instrumental in guiding GLAUKOS CORP through periods of significant growth and expansion. Thurman brings a wealth of experience to his position, having held various senior financial roles throughout his career. Prior to joining GLAUKOS CORP, he served as the Vice President of Finance and Corporate Controller at another prominent medical device company, where he played a key role in driving financial performance and operational efficiency. Thurman's expertise in financial management, coupled with his deep understanding of the healthcare industry, has enabled him to make significant contributions to GLAUKOS CORP's success. Under his guidance, the company has achieved strong financial results and has been able to invest in research and development to bring innovative treatments to patients worldwide. In addition to his professional achievements, Thurman is known for his commitment to fostering a culture of transparency and accountability within the organization. He actively engages with investors and analysts to provide clear and comprehensive insights into the company's financial performance and strategic direction. Thurman's leadership has been recognized by his peers and industry experts, and he continues to be a driving force behind GLAUKOS CORP's mission to transform the treatment of eye diseases and improve patient outcomes.